In the context of RECIST, target lesions are selected based on their size and visibility and are used to quantitatively evaluate treatment response. Typically, up to five lesions total (and no more than two per organ) are identified as target lesions. Non-target lesions are all other lesions that are not selected as target lesions and are assessed qualitatively.
